Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other 1

Conditions

Urinary Incontinence 2Prostatic Neoplasms 2Sexual Dysfunction, Physiological 1Prostatic Hyperplasia 1Neoplasms 1

Interventions

Docetaxel 26Prednisone 16Magnetic Resonance Spectroscopy 16Specimen Handling 15PROSTVAC 14Biopsy 12Goserelin 11bicalutamide 10Leuprolide 9sargramostim 8Estramustine 8Radiotherapy 7Lycopene 7High-Intensity Focused Ultrasound Ablation 7Flutamide 7Bevacizumab 7enzalutamide 6Thalidomide 6Mitoxantrone 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6ixabepilone 5olaparib 4cediranib 4Tomography, X-Ray Computed 4Radiation 4Nivolumab 4Magnetic Resonance Imaging 4Androgen Antagonists 4Amplified Fragment Length Polymorphism Analysis 4temsirolimus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Prostatic Neoplasms × Biofeedback, Psychology × Clear all
NCT00212264 2016-04-11

Conservative Treatment of Postprostatectomy Incontinence

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase NA Completed
208 enrolled 9 charts
Genitourinary

Prostatic Neoplasms, Urinary Incontinence

NCT00632138 2013-08-07

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

National Cancer Institute (NCI)

Phase 3 Completed
800 enrolled
GenitourinaryOther

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡